Stage IB-IIIA non-small cell lung carcinoma

Clinical trials for Stage IB-IIIA non-small cell lung carcinoma explained in plain language.

Never miss a new study

Get alerted when new Stage IB-IIIA non-small cell lung carcinoma trials appear

Sign up with your email to follow new studies for Stage IB-IIIA non-small cell lung carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New pill could keep lung cancer away after surgery

Disease control Ongoing

This phase 3 trial tests a daily pill called osimertinib (AZD9291) against a placebo in 682 people with a specific type of lung cancer (EGFR-mutated, stages IB to IIIA) who have had surgery to remove their tumor. The goal is to see if the drug can delay or prevent the cancer from…

Matched conditions: STAGE IB-IIIA NON-SMALL CELL LUNG CARCINOMA

Phase 3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC

Stage IB-IIIA non-small cell lung carcinoma

Get alerted when new Stage IB-IIIA non-small cell lung carcinoma trials appear

New pill could keep lung cancer away after surgery